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Abstract
This paper presents an exploration of strategies undertaken by a consortium of clinical teams and manufacturers to proactively 
prepare and support use of new categories of medical devices.  Potential avenues of exploration include leveraging other 
domains, such as the US Space program, providing innovative methods of training and research and development in known areas 
of concern such as systems integration.  By a commitment to creating a safer system, we are committing to providing safer care 
to patients. We believe incorporating the ‘lessons learned’ from the largest possible set of real-world scenarios, into the design 
and use of medical devices, will accelerate success.
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1. Introduction
The purpose of this paper is to inspire an exploration of strategies to proactively prepare and support clinical 
teams using new categories of medical devices.  As part of seeking authorization from the U.S. Food and Drug 
Administration (FDA) for commercial distribution of medical devices in the U.S., device manufacturers perform 
testing and Failure Mode and Effects Analysis (FMEA) to demonstrate robust design.  However, especially for the 
initial offering of a new category of device, the manufacturer’s engineering design team can only provide data on 
what they were able to envision, analyze or discover in their assessment period.  Once in use, as new issues are 
discovered, the regulatory framework mandates sending reports to the FDA, and requires the manufacturer to 
communicate widely to customers their plan to recall or otherwise rectify the newly-identified issue.
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As the complexity of medical technology increases, it seems prudent to consider augmenting analyses outlined by 
the regulatory requirements with a more real-time dynamic analysis of compiled failure modes and measured 
impacts/effects. By assembling a consortium of like-minded clinical teams, we’ve begun actively seeking out as 
many perspectives as possible for ‘what could go wrong’ in the variety of conditions envisioned for task 
performance. This approach is similar to how one would train an astronaut space crew for a complex task where 
success was critical to survival. The authors were part of NASA’s Crew Interface Analysis team at Johnson Space 
Center, who utilized six human factors laboratories to create and assess candidate hardware and scenarios for Space 
Shuttle and International Space Station robotic system definition.  We’d like to share the proposed plan and invite 
others to join in partnership.
As new dimensions of patient care arise, the associated introduction of device categories present opportunities to 
leverage the large pool of users in what is traditionally required as a FMEA. This presentation discusses a pilot 
study with robot devices, sharing the strategic approach and results.
2. Potential avenues
2.1. Leveraging other domains
By becoming intimate with the design and existing engineering analysis of robotic systems utilized for human 
surgical procedures, the consortium will identify a number of challenging scenarios that could plausibly occur while 
performing procedures as part of patient care.  With medical device manufacturers as a critical part of the 
consortium and discussion, the hope is that we can identify early detection strategies or perhaps even introduce new 
user cues to better assist in recognition and successful reaction to a situation that could lead to an unsafe condition or 
adverse outcome.  Just as the crew training experts at Johnson Space Center gather a team to script simulations to 
enhance recognition of changing situational status, and learn the nuances and interdependencies of using a robotic 
arm as part of the large space craft system, the consortium will create a shared awareness of what is known and 
unknown about the performance envelope associated with robotic surgery.
2.2. Better training – Look and feel
Once the consortium identifies a set of challenging, but not unrealistic scenarios, and can present outcomes 
associated with choices surgeons could potentially make for those scenarios, we will create a training library to 
augment the material provided by the medical device manufacturer.  Basically, by creating a way to simulate and 
play challenging scenarios through the robotic surgical system, a clinical team can pause, discuss, and share 
observations and actually ‘feel and see’ how the device performs in an unusual but critical situation. The creation of 
a set of training simulation scenarios that present critical but unusual situations to surgical teams so they are aware 
and can better anticipate and more quickly take appropriate action is the first element of the consortium’s focus.
Over time, we will expand the training library by adding actual recordings of challenging surgeries, to share both 
successful as well as inadvertent performance in unusual or new conditions or situations.  This will present learning
opportunities through seeing and feeling another surgeon’s task.  Imagine the wealth of professional learning, as a
surgeon can experience the most interesting cases prior to actual patient surgery. An interested colleague could feel 
the controller positioning and see the associated visual information that another surgeon experienced, thus inviting 
sharing/discussion across the profession.  This ability to capture a real procedure will also allow other surgeons to 
experience the ‘look and feel’ of a variety of similar procedures prior to performing robotic surgery on the upcoming 
patient – similar to aviators practicing  touch-and-go maneuvers to prepare for the critical task of landing their 
aircraft. 
2.3. Better analysis after failure – The blackbox approach
An important part of this consortium vision is to create a ‘blackbox’ for the robotic surgical system; a system that 
could gather data in a secure and de-identified manner, and allow a playback of the task.  Again, this presents an 
opportunity to replay a surgical robotic task for post-procedure discussion/debriefing and self-learning/process 
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improvement for clinical teams; also for providing a platform for surgical teams to practice a large range of cases 
without risk to patient safety; and for allowing the experiential depiction of cases that will advance the informed 
professional discussions critical to improved practice. The ‘blackbox’ capability encompasses the second element of 
the consortium’s focus.
2.4. Research and development for a safer system – Camera movement
Finally, identifying and designing advanced methods for safer surgeries comprises the third focus of the 
consortium.  One of the main safety issues observed in the early years of robotic surgery is camera movement.  The 
surgeons doing surgery have to repeatedly stop surgery, move the camera, and then continue with the surgery.  Since 
this is quite a disruptive process the surgeon sometimes settles for non-optimal views and his or her instruments can 
leave the field of view.  The consortium will investigate the ability to coordinate the two systems. Again, leveraging 
what  the Space Shuttle and Space Station robotic development experience taught, it is envisioned that an analysis of 
user-aids such as overlays, display strategies, instrument guides, target confirmation, or perhaps even a ‘mission 
control center’ type of coaching/consulting could improve the ease of task performance.
3. Conclusions
Please note that this discussion is not meant to discredit the current regulatory framework or manufacturers’ 
competency. Rather, it is to recognize the increasing rate of technological change and propose an agile augmentation 
of what is required with what we can know about system performance.  Bringing together interested parties around a 
core set of advanced analysis might truly accelerate our best understanding of how to support safe care using 
complex new medical devices/systems. The intended outcome is a focused exploration of ‘off –nominal’ scenarios 
to develop best practices for ‘what you would want to do’ in these cases.  Currently, the hope is that every user 
routinely performs in the ‘good enough’ range; we want to increase the number of situations where that hope is 
realized.
In summary, along with the current regulatory and manufacturer responsibility to develop safe and effective 
medical devices, a consortium of clinical teams and manufacturers are pursuing an innovative leveraging of NASA’s 
experience with supporting robotic operations in the unforgiving environment of Space.  It is envisioned that the 
consortium team will create a set of plausible, but challenging scenarios so that clinical teams can prepare for a 
wider range of situations than they might see in practice.  The consortium will also create a ‘black box’ system to 
capture and playback procedures, so clinical teams can improve performance with enhanced pre-brief and debrief 
support; and foster organizational learning by allowing surgical teams to ‘experience’and discuss a diverse range of 
clinical cases without putting patients at risk.  Finally, the consortium will explore system improvements to assure 
safer surgeries, based on controlling or eliminating the clinical team’s ability to use either the technology itself or 
the information available for interpretation differently than intended.  
By a commitment to creating a safer system, we are committing to providing safer care to patients. We believe 
incorporating the ‘lessons learned’ from the largest possible set of real-world scenarios, into the design and use of 
medical devices, will accelerate success.
